• Science
  • Metabotropic Glutamate Receptors
  • mGlu2/3 Receptor and MDD
  • mGlu2/3 Receptor and TRD
  • mGlu2/3 Receptor and AD
• Disease Areas
  • Major Depressive Disorder (MDD)
  • Treatment Resistant Depression (TRD)
  • Alzheimer's Disease (AD)
• Pipeline
  • Pipeline Overview
  • BCI-632 and its Oral Prodrugs
  • BCI-540 (coluracetam)
  • BCI-224 (sabcomeline)
  • BCI-952
• Collaboration
  • Partnering Opportunities
• Company
  • People
  • Investors
  • News
  • Contact

Contact: 858-812-7700  |  © 2011 BrainCells Inc. All rights reserved.